MindMaze Therapeutics Holding SA (V6M)
Market Open
11 Aug, 11:18
€
0. 24
-0
-1.4113%
€
- Market Cap
- P/E Ratio
- Div Yield
396 Volume
- Eps
€ 0.25
Previous Close Want to track V6M and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MindMaze Therapeutics Holding SA (V6M) Statistics
Valuation metrics
Market Cap -
Enterprise value -12.94M
Trailing P/E (ttm) -0.34
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -1.54
Enterprise Value/EBITDA 2.59
Overview
Shares outstanding 12.58M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 215
Average volume (90 days) 265
Price summary
52-Week low 0.16
52-Week high 3.92
Beta -
50-Day moving average 2.99
200-Day moving average 2.12
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:400
Last split Date 5 May 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2024
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.69%
Operating margin -2.27%
Operational effectiveness
Return on assets -0.32%
Return on equity -0.47%
Income Statement
Revenue (ttm) 8.42M
Revenue per share (ttm) 0.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) 5.84M
EBITDA -
Net income to common (ttm) -17.12M
Diluted EPS (ttm) -1.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) 1.9M
Total Debt/Equity (mrq) 0.06
Current ratio (mrq) 4.05%
Book value per share (mrq) -
Cash Flow
Cash flow statement -17.01M
Levered free cash flow (LFCF) -17.12M
